Diwakar Davar and Jason Luke discuss high-risk melanoma from the NADINA trial
Jun 27, 2024, 15:26

Diwakar Davar and Jason Luke discuss high-risk melanoma from the NADINA trial

The American Society of Clinical Oncology (ASCO) shared on X:

Diwakar Davar and Jason Luke of UPMC Hillman Cancer Center discuss exciting advances in high-risk melanoma from the NADINA trial and other emerging approaches in immunotherapy from ASCO24 on the ASCO Daily News Podcast.”

Source: ASCO/X